Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Blood Protein Signature Diagnoses Pediatric IBD and Distinguishes Subtypes

By LabMedica International staff writers
Posted on 25 Jun 2026

Confirming pediatric inflammatory bowel disease (IBD) often requires imaging, endoscopy, and histopathology, prolonging time to diagnosis. More...

Reliable, noninvasive blood tests remain an unmet need in routine evaluation. Differentiating Crohn's disease from ulcerative colitis is another critical challenge at presentation. A new study shows that a blood proteomic signature can identify pediatric IBD and distinguish its subtypes.

Researchers at Beth Israel Deaconess Medical Center (BIDMC) and Mass General Brigham for Children used large-scale blood proteomics to define distinct protein patterns associated with pediatric IBD. The approach culminated in a four‑protein signature intended for noninvasive diagnosis and subtype differentiation. Investigators aimed to enable differential diagnosis using routinely accessible assays.

In the discovery phase, the team measured the expression of roughly 1,300 circulating proteins and identified a disease‑associated pattern across children with and without IBD. Machine learning then narrowed this to eight proteins with strong diagnostic performance. The investigators further reduced the signal to four proteins and validated it using conventional, clinically available tests.

Samples came from an initial group of 47 children, followed by two larger cohorts of 295 and 105 children for validation. The four‑protein test identified IBD with high accuracy in the 80%–90% range. A separate four‑protein panel achieved more than 90% predictive performance for distinguishing ulcerative colitis from Crohn's disease.

The findings are published in eBioMedicine in a case–control study titled “Serum proteomics in paediatric inflammatory bowel disease from a case–control study: biomarker discovery and ulcerative colitis–Crohn's disease differentiation.” Beyond diagnostic utility, the protein patterns illuminated inflammatory pathways that differ between Crohn's disease and ulcerative colitis, which the authors note could inform future efforts toward targeted therapies and precision medicine approaches.

“Our findings measuring expression of 1,300 proteins in blood samples demonstrate the utility of blood proteomics in identifying disease-specific biomarkers and new noninvasive tests for differential diagnosis in pediatric IBD as well as defining the underlying pathophysiological mechanisms. A validated blood-based diagnostic approach could help reduce diagnostic delays, minimize invasive procedures, and support earlier, more personalized treatment decisions for children with IBD,” said co-senior author Towia Libermann, Ph.D., director of the Genomics, Proteomics, Bioinformatics, and Systems Biology Center at BIDMC.

“Noninvasive diagnostic tools can contribute to the diagnosis of inflammatory bowel disease but are not yet at the point of replacing standard clinical and pathologic data. Nevertheless, the data from these new proteomic platforms represent a much-needed advancement in the care of children with Crohn's disease and ulcerative colitis as we learn how best to not only treat diseases but also to personalize treatment,” said co-senior author Harland Winter, MD, co-director of the Center for Pediatric Inflammatory Bowel Disease at Mass General Brigham for Children.

Related Links
Beth Israel Deaconess Medical Center
Mass General Brigham for Children


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.